Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "DL likely welcomes this...could it also be the opposite?" I doubt it,

the ITC strategy is a legitimate action used by many other companies in our situation. Besides, didn't he successfully appeal to the ITC for one of the other patents he licenses ? I don't recall for sure but I think he did and that a license followed on the rulings heels.

Regardless, imo, at this point, "TIME" and "efficiency" will be the core calculus for all decisions involving infringment settlement considerations and selective prosecution efforts.

Share
New Message
Please login to post a reply